drugset / Trial / NCT03263780
High Resolution PET-MRI Before Prostate Cancer HIFU
NaSingle-groupOpen-labelOther
Summary
This prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-fluciclovine PET-MRI) will detect prostate cancers not seen on standard multiparametric prostate MRI in patients considered candidates for focal HIFU.
Timeline
- Start
- 2017-12-07
- Primary completion
- 2020-01-08
- Completion
- 2020-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-fluciclovine | Diagnostic / imaging agent | 370 mbq | — |